Skip to contents

Mehra Golshan, MD, MBA
Associate Surgeon, Brigham and Women's Hospital
Associate Professor of Surgery, Harvard Medical School
Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology, Brigham and Women's Hospital

Brigham and Women's Hospital
Department of Surgery
75 Francis Street
Boston, MA 02115


Edit Profile


Research Narrative:

Dr. Mehra Golshan is the incumbent Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology at the Brigham and Women’s Hospital. He is also the Director of the Breast Surgical Oncology Fellowship at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School.  He chairs the Dana Farber/Brigham and Women’s Cancer Center:  Committee for the American College of Surgeon’s Commission on Cancer and serves as the Cancer Liaison Physician as well. 

Dr. Golshan received his medical degree from Case Western Reserve University School of Medicine. He completed a residency in general surgery at Rush-Presbyterian-Saint Luke's Medical Center and a breast surgical oncology fellowship at Northwestern Memorial Hospital. He is board certified in surgery.  He runs a busy clinical practice focused exclusively on breast surgical oncology, a robust clinical trials group and completed his MBA at MIT Sloan School of Management in May of 2019.

The author of over 115 peer-reviewed publications and recipient of funding from the Breast Cancer Research Foundation and the National Institutes of Health, Dr. Golshan focuses his clinical research on minimizing the extent of surgery required for women with breast cancer through the use of neoadjuvant therapies and novel intra-operative imaging and margin analysis techniques. He is studying the use of intra-operative diagnostic biomarkers and tools in BWH’s Advanced Multimodality Image Guided Operative Suite to determine if they can identify and remove residual tumor with the aim of improving patient outcomes and reducing re-excision rates. Dr. Golshan is also a leading researcher on tailoring the extent of surgery and therapy for women with early-stage breast cancer. Dr. Golshan has been consistently named one of America’s Top Doctors by Castle Connolly and named a top surgeon in Boston Magazine.


Education:
MIT Sloan School of Management, 2019, MBA
Case Western Reserve University, 1996, MD

Additional News:
AMIGO Operating Room Story http://boston.cbslocal.com/2012/12/07/new-operating-room-at-bwh-helps-breast-cancer-patients-avoid-multiple-surgeries/

Publications (Pulled from Harvard Catalyst Profiles):

1. Özkurt E, Sakai T, Wong SM, Tukenmez M, Golshan M. Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? Ann Surg Oncol. 2019 Jul 24.

2. Wong SM, Chun YS, Sagara Y, Golshan M, Erdmann-Sager J. National Patterns of Breast Reconstruction and Nipple-Sparing Mastectomy for Breast Cancer, 2005-2015. Ann Surg Oncol. 2019 Jul 24.

3. Wong SM, Weiss A, Mittendorf EA, King TA, Golshan M. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis. Ann Surg Oncol. 2019 Jul 24.

4. Sakai T, Ozkurt E, DeSantis S, Wong SM, Rosenbaum L, Zheng H, Golshan M. National trends of synchronous bilateral breast cancer incidence in the United States. Breast Cancer Res Treat. 2019 Jul 19.

5. Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2019 Jun 21.

6. Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, Pun M, Campbell N, Dowling RJO, Chang MC, Tolaney S, Chagpar AB, Yung RL, Freedman RA, Dominici LS, Golshan M, Rhei E, Taneja K, Huang Y, Brown M, Winer EP, Jeselsohn R, Irwin ML. Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study. Clin Cancer Res. 2019 Apr 24.

7. Cole AP, Krasnova A, Ramaswamy A, Fletcher SA, Friedlander DF, McNabb-Baltar J, Melnitchouk N, Lipsitz SR, Sun M, Kibel AS, Golshan M, Haider AH, Weissman JS, Trinh QD. Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program. J Oncol Pract. 2019 Jun; 15(6):e547-e559.

8. Heshmati K, Harris DA, Rosner B, Pranckevicius E, Ardestani A, Cho N, Golshan M, Ng WT, Ligibel J, Tavakkoli A, Sheu E. Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study. Obes Surg. 2019 Apr; 29(4):1092-1098.

9. Zinboonyahgoon N, Vlassakov K, Lirk P, Spivey T, King T, Dominici L, Golshan M, Strichartz G, Edwards R, Schreiber K. Benefit of regional anaesthesia on postoperative pain following mastectomy: the influence of catastrophising. Br J Anaesth. 2019 08; 123(2):e293-e302.

10. Cole AP, Nguyen DD, Meirkhanov A, Golshan M, Melnitchouk N, Lipsitz SR, Kilbridge KL, Kibel AS, Cooper Z, Weissman J, Trinh QD. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States. JAMA Netw Open. 2019 Feb 01; 2(2):e187633.